Homeostatic synaptic plasticity is a form of non-Hebbian plasticity that maintains stability of the network and fidelity for information processing in response to prolonged perturbation of network and synaptic activity. Prolonged blockade of synaptic activity decreases resting Ca 2+ levels in neurons, thereby inducing retinoic acid (RA) synthesis and RA-dependent homeostatic synaptic plasticity; however, the signal transduction pathway that links reduced Ca 2+ -levels to RA synthesis remains unknown. Here we identify the Ca 2+ -dependent protein phosphatase calcineurin (CaN) as a key regulator for RA synthesis and homeostatic synaptic plasticity. Prolonged inhibition of CaN activity promotes RA synthesis in neurons, and leads to increased excitatory and decreased inhibitory synaptic transmission. These effects of CaN inhibitors on synaptic transmission are blocked by pharmacological inhibitors of RA synthesis or acute genetic deletion of the RA receptor RARα. Thus, CaN, acting upstream of RA, plays a critical role in gating RA signaling pathway in response to synaptic activity. Moreover, activity blockadeinduced homeostatic synaptic plasticity is absent in CaN knockout neurons, demonstrating the essential role of CaN in RA-dependent homeostatic synaptic plasticity. Interestingly, in GluA1 S831A and S845A knockin mice, CaN inhibitor-and RA-induced regulation of synaptic transmission is intact, suggesting that phosphorylation of GluA1 C-terminal serine residues S831 and S845 is not required for CaN inhibitor-or RA-induced homeostatic synaptic plasticity. Thus, our study uncovers an unforeseen role of CaN in postsynaptic signaling, and defines CaN as the Ca 2+ -sensing signaling molecule that mediates RA-dependent homeostatic synaptic plasticity.
retinoic acid | retinoic acid receptor RARα | homeostatic synaptic plasticity | calcineurin | AMPA receptor trafficking S ynaptic plasticity, a fundamental feature of the nervous system, is defined as modification of synaptic strength based on experience and activity history. Homeostatic synaptic plasticity is a type of compensatory mechanism activated during chronic elevation or reduction of network activity to modulate synaptic strength in the opposite direction (for example, reduced network activity leads to increased synaptic strength) (1, 2) . Retinoic acid (RA) is a key signaling molecule in a form of homeostatic synaptic plasticity induced by reduced excitatory synaptic activity (3) (4) (5) . Prolonged inhibition of excitatory synaptic transmission leads to a compensatory increase in synaptic excitation and a decrease in synaptic inhibition (4, 5) . Both of these processes require RA synthesis. It also has been shown that dendritic Ca 2+ levels directly govern the synthesis of RA; basal Ca 2+ levels maintained by normal synaptic transmission are sufficient to suppress RA synthesis. Upon synaptic activity inhibition, reduced Ca 2+ levels de-repress RA synthesis and activate RA-dependent homeostatic synaptic mechanisms (6) . Thus, a Ca 2+ -dependent signaling molecule that is sensitive to changes in basal Ca 2+ levels must be involved in synaptic RA signaling. Ca
2+
-dependent protein kinases and phosphatases are critical components of signaling pathways involved in synaptic plasticity (7, 8) . For example, regulation of the phosphorylation of key serine residues in the C-terminal sequences of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) type glutamate receptor (AMPAR) subunit GluA1 by kinases (i.e., PKA, PKC, and CaMKII) and phosphatases [i.e., calcineurin (CaN) and PP2A] is thought to play major roles in governing AMPAR trafficking in and out of the synaptic membrane and to mediate the expression of well-established forms of synaptic plasticity, such as long-term potentiation (LTP) and long-term depression (LTD) (9) (10) (11) (12) . A recent study examining the stoichiometry of AMPAR phosphorylation revealed surprisingly low levels of phosphorylated GluA1 in neurons (13) , however, suggesting that the phosphorylation of AMPARs might not be involved in homeostatic plasticity, and that other mechanisms may be in play.
In the present study, we identified CaN as the Ca
-dependent signaling molecule that regulates RA synthesis in neurons in an activity-dependent manner. Inhibition of CaN activity triggers RA synthesis, suggesting that basal CaN activity, supported by normal synaptic transmission, is sufficient to suppress RA synthesis in an active neural network. In CaN-deficient neurons, synaptic activity blockade-induced RA-dependent forms of homeostatic synaptic plasticity are absent. Similar to direct RA application, CaN inhibition enhances excitatory synaptic transmission and
Significance
Chronic reduction of synaptic activity in neural networks leads to compensatory changes at both excitatory and inhibitory synapses, a phenomenon known as homeostatic synaptic plasticity. Postsynaptic activity/Ca 2+ -dependent regulation of retinoic acid (RA) synthesis is critically involved in homeostatic synaptic plasticity; however, the signaling molecule that gates RA synthesis in response to Ca 2+ level changes remains unknown. Using pharmacologic and genetic manipulations, we show that calcineurin (CaN) activity, which is regulated by postsynaptic Ca 2+ levels, directly controls RA synthesis. Inhibiting CaN activity or genetic ablation of CaN leads to homeostatic modulation of synaptic transmission in an RA signalingdependent manner. These findings uncover the molecular mechanism by which activity regulates synaptic strength through RA synthesis. -activated targets using a combination of shRNA-based and pharmacology-based methods, along with a previously established RA synthesis reporter system (4, 6). We found that inhibiting CaN, a Ca 2+ /calmodulin-dependent serine-threonine phosphatase, significantly increased RA synthesis in cultured rat hippocampal neurons. Specifically, similar to the effect of RA and activity blockers [tetrodotoxin (TTX) plus the AMPAR antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (TTX+CNQX)], treating neurons with FK506, a CaN inhibitor, for 10 h after transfection of an RA response element (RARE)-based GFP reporter significantly increased expression of the RA reporter (Fig. 1A) . The increase in RARE-GFP reporter expression was due to RA synthesis, because it could be blocked by N,N-diethylaminobenzaldehyde (DEAB), a drug that inhibits the RA synthesis enzymes retinal dehydrogenases (RALDHs) (14) (Fig. 1A) . FK1012, a derivative of FK506 that does not inhibit CaN activity (15) , failed to increase RARE-GFP reporter expression (Fig. 1A) .
Inhibition of CaN Activity Regulates Synaptic Transmission in an RADependent Manner. We have previously shown that RA mediates homeostatic synaptic plasticity by increasing synaptic excitation and decreasing synaptic inhibition (4, 5) . If CaN operates upstream of RA synthesis in homeostatic synaptic plasticity, then blocking CaN activity also should regulate synaptic strength in a manner similar to RA. Moreover, it should occlude further modulation of synaptic strength by RA. Indeed, similar to acute (2-4 h) RA treatment, prolonged (36 h) blockade of CaN activity in cultured organotypic hippocampal slices with another CaN inhibitor, cyclosporine A (CsA), increased synaptic excitation and decreased synaptic inhibition, as manifested by increased miniature excitatory postsynaptic current (mEPSC) amplitudes (Fig. 1B) and decreased miniature inhibitory synaptic current (mIPSC) amplitudes (Fig. 1C) . Importantly, the addition of RA to CsA-treated slices did not further increase mEPSC amplitudes or further decrease mIPSC amplitudes ( Fig. 1 B and C) , indicating that the effects of RA and CaN inhibition converge to the same downstream signaling pathway.
To further test whether CaN operates upstream of RA synthesis, we examined the effect of the RA synthesis blocker DEAB on CaN inhibitor-induced changes in synaptic strength. Both FK506 and CsA, but not FK1012, induced a robust increase in mEPSC amplitudes (Fig. 1D ) and a decrease in mIPSC amplitudes (Fig. 1E ). Both synaptic changes were blocked by coapplication of DEAB ( Fig. 1 D and E) . DEAB treatment alone did not cause any changes in synaptic transmission (Fig.  S1 ). These effects on synaptic transmission were specific to CaN; inhibition of protein phosphatases PP1 and PP2A with okadaic acid did not change mEPSC and mIPSC amplitudes ( Fig. 1 D and E) . Passive membrane properties of neurons were not altered by these drugs (Fig. S2 ). In addition, inhibiting Ca 2+ -activated kinases, such as PKC and CaMKII, did not lead to any significant changes in synaptic transmission (Fig. S3) . Thus, inhibition of CaN activity leads to changes in excitatory and inhibitory synaptic transmission through a pathway that promotes RA synthesis.
RA Receptor RARα Mediates CaN Inhibitor-Induced Regulation of
Synaptic Transmission. Our previous work showed that synaptic RA signaling is mediated by the RA receptor RARα, a member of the nuclear hormone receptor family that is also localized, at least in part, to the cytoplasm (4, 16 ). Thus, we tested whether the effects of CaN inhibition also require RARα, using conditional RARα knockout (KO) neurons. Selective deletion of RARα in postsynaptic neurons was achieved by injecting lentiviruses expressing Cre recombinase into the CA1 pyramidal cell layer of cultured slices from conditional RARα KO mice (17, 18) (Fig. S4A) . Compared with the neighboring WT (uninfected) neurons, whose mEPSC amplitudes were significantly increased by CsA, RARα KO (infected) neurons failed to respond to CsA treatment ( Fig. 2A) . Similarly, the effect of CsA on mIPSC amplitudes was blocked in RARα KO neurons (Fig. 2B) . Deletion of RARα did not affect neuronal health, as indicated by the neurons' normal morphology and passive membrane properties (Fig. S4) .
The results obtained with miniature synaptic transmission were corroborated by results of evoked synaptic transmission (eEPSCs and eIPSCs) in WT and RARα KO neurons. We directly compared the evoked response amplitudes in neighboring pairs of WT (uninfected) and RARα KO (Cre-infected) neurons (Fig. 2C) . RARα deletion did not change eEPSC amplitudes mediated by AMPARs (Fig. 2 D and E) or NMDA receptors (NMDARs) (Fig. 2 D and F) under control conditions; however, in CsA-treated slices, WT neurons exhibited significantly greater AMPAR eEPSC amplitudes than their RARα KO neighbors ( Fig. 2 D and E) , indicating a lack of increase in eEPSC size in the KO neurons. No difference was observed in the NMDAR eEPSC amplitudes (Fig. 2 D and F) . The selective increase in AMPAR-mediated EPSCs by CsA in WT neurons was also reflected by a significant increase in AMPAR/NMDAR ratios of the eEPSCs (Fig. S5 ). This increased AMPAR/NMDAR ratio was absent in RARα KO neurons (Fig. S5) . Likewise, whereas RARα deletion did not alter eIPSC amplitudes (Fig. 2 G and H) , it did significantly impair the depression of eIPSCs by CsA ( Fig. 2 G and H) . In contrast, neurons infected with lentiviruses expressing an inactive form of Cre recombinase (mCre) responded to CsA treatment similarly as their uninfected neighbors for both eEPSCs and eIPSCs ( Fig. S6 A and B) . Taken together, these results demonstrate that the altered excitatory and inhibitory synaptic transmission by CaN inhibition is mediated by the RA signaling pathway.
CaN Is Critically Involved in Activity Blockade-Induced Homeostatic Synaptic Plasticity. Having established the connection between CaN activity and RA signaling, we next asked whether CaN is involved in activity blockade-induced homeostatic plasticity, which requires RA signaling (4, 6) . We performed three lines of experiments to test this. First, we asked whether CNQX-and CsA-induced homeostatic plasticity occlude each other. Indeed, both CNQX-and CsA treatment increased mEPSC amplitudes, but cotreatment of CNQX and CsA did not further increase mEPSC amplitudes (Fig. S7A) , or further decrease mIPSC amplitudes (Fig. S7B) . The lack of additive effect between CNQX and CsA supports the idea that synaptic activity blockade and inhibition of CaN activity induce homeostatic synaptic plasticity through a converging signaling pathway.
Second, we tested whether persistent CaN activity prevents changes in synaptic strength induced by prolonged activity blockade. We generated a constitutively active CaN (CA-CaN) by deleting the autoinhibitory domain (19) and expressed CACaN in CA1 pyramidal neurons in cultured slices with lentivirus injection. Indeed, CA-CaN expression blocked CNQX-induced up-regulation of mEPSC amplitudes and down-regulation of mIPSC amplitudes (Fig. S8) . We also noticed, however, that neurons expressing CA-CaN were less healthy than their uninfected neighbors. Thus, in a third line of experiments, we further explored CaN's involvement in homeostatic synaptic plasticity using the genetic deletion of CaN in the CaN-B KO mice. CaN is a heterodimer of a 61-kDa calmodulin-binding catalytic subunit (CaN-A) and a 19-kDa Ca
2+
-binding regulatory subunit (CaN-B) . Deletion of CaN-B leads to rapid degradation of CaN-A, completely inactivating CaN.
Owing to the high stability of CaN protein and potential incomplete removal of CaN (Fig. S9) , we generated heterozygous CaN-B null/floxed mice by crossing constitutive CaN-B KO mice with the conditional CaN-B KO mice. Null/floxed compound heterozygous mice are viable and fertile. We then induced complete KO of CaN-B by injecting Cre-expressing lentiviruses into the CA1 region of cultured hippocampal slices prepared from the null/floxed mice (Figs. S9 and S10A) .
We first verified the specificity of CsA, which should not be effective in CaN-B KO neurons. Indeed, whereas CsA significantly increased mEPSC amplitudes in WT neurons (Fig. 3A) , it failed to change mEPSC amplitudes in CaN-B KO neurons (Fig.  3A) . The CaN-B KO had no effect on neuronal health, as evidenced by normal neuronal morphology and passive membrane properties (Fig. S10) . We then examined whether CaN-B deletion affects RA-dependent, activity blockade-induced homeostatic synaptic plasticity. Consistent with previous reports (6), prolonged treatment (36 h) of cultured slices with CNQX increased mEPSC amplitudes in WT neurons, but not in CaN-B KO neurons (Fig. 3B) .
We next assessed excitatory synaptic transmission with evoked responses. Of note, CaN-B KO neurons have an elevated basal excitatory synaptic response, reflected by greater mEPSC, AMPAR eEPSC, and NMDAR eEPSC amplitudes in CaN-B KO neurons compared with their WT controls ( Fig. 3 A and C and  Fig. S11 ). This increase in basal excitatory transmission has been reported previously, and attributed to transcriptional control of morphological and electrophysiological properties of neurons mediated by distinct CaN-NFAT interactions (20) . This increased basal synaptic transmission is specific to CaN-B KO neurons, with no difference observed between mCre-infected and WT neurons (Fig. S12A) . In both CsA-treated and CNQX-treated slices, WT neurons, but not CaN-B KO neurons, exhibited increased eEPSC amplitudes, thus eliminating the difference between WT and CaN-B KO neurons (Fig. 3 D and E) . We also examined inhibitory synaptic transmission in CaN-B KO neurons. Different from excitatory synaptic transmission, neither Cre infection or mCre infection altered basal inhibitory synaptic responses (Fig. 4 A-C and Fig. S12B ). However, neither CsA nor CNQX treatment decreased inhibitory synaptic responses in CaN-B KO neurons, as measured by mIPSC and eIPSC recordings (Fig. 4 A-E) , indicating that activity blockade-induced homeostatic synaptic plasticity at inhibitory synapses is also blocked by CaN deletion. In addition, we treated CaN-B KO neurons with RA, which successfully reduced mIPSC amplitudes in both WT and CaN-B KO neurons (Fig. 4F) , indicating that RA acts downstream of CaN to modulate synaptic transmission. Interestingly, RA did not further increase mEPSC amplitudes in CaN-B KO neurons (Fig. 3F) , likely because of elevated basal transmission preventing further increases owing to synaptic constraints. Taken together, these results support the notion that CaN activity, acting upstream of RA synthesis, is an essential component of activity blockade-induced homeostatic synaptic plasticity.
GluA1 Phosphorylation at S831 and S845 Is Not Required for RADependent Homeostatic Synaptic Plasticity. The AMPAR GluA1 subunit contains multiple C-terminal phosphorylation sites whose phosphorylation state is regulated by various kinases and phosphatases (21) (22) (23) . Both GluA1 S831 and S845 were hyperphosphorylated in the hippocampus of conditional CaN-B KO mice crossed to mice expressing Cre under control of the Emx1 promoter, which activates Cre expression in all excitatory forebrain neurons (Fig. 5A) . The phosphorylation state of these two serine residues is thought to regulate trafficking of AMPARs at synaptic membranes during Hebbian plasticity (11) . Thus, we were curious to know whether inhibition of CaN may induce homeostatic synaptic plasticity by increasing the phosphorylation of S831 and S845, in addition to its stimulation of RA synthesis. To address this question, we used GluA1 S831A and S845A KI mice in which phosphorylation of these two sites are blocked (24) . Treatment with RA, CsA, or CNQX significantly increased the mEPSC amplitudes in the S831A and S845A KI mice to levels similar to those seen in their WT littermates (Fig. 5 B and C) . Therefore, although blocking CaN activity may significantly increase the phosphorylation of GluA1 S831 and S845, phosphorylation of these two sites of GluA1 is not required for RA-mediated homeostatic synaptic plasticity.
Discussion
In this study, we have uncovered a previously unknown function of CaN in regulating RA synthesis. Although RA is increasingly recognized as an active signaling molecule in the adult brain (25) , little is known about how RA synthesis is regulated in the adult nervous system. Our previous work showed that regular basal Ca 2+ levels in neurons maintained by normal synaptic transmission is sufficient to suppress RA synthesis, and that a decrease in basal Ca 2+ levels stimulates RA synthesis (6). Here we have identified CaN as the signaling molecule linking Ca 2+ levels to RA synthesis, thus revealing a crucial component of the pathway for the activity-dependent regulation of RA synthesis.
How does CaN regulate RA synthesis? RA is produced through oxidation of retinal by RALDHs (26, 27) . During development, RA levels are controlled largely by changes in RALDH expression levels (28) . There are three RALDHs, designated RALDH1-3, which display nonoverlapping tissue-specific patterns of expression during embryogenesis (29) . These enzymes are also expressed in the adult mammalian brain (30, 31) . Given the relatively high expression levels of RALDHs in the brain (4, 30) , it is likely that the enzymatic activity of RALDHs is acutely regulated by posttranslational modifications, such as phosphorylation. Indeed, phosphorylation sites on RALDHs have been reported by recent quantitative phosphoproteomics studies (32) (33) (34) (35) (36) (37) (38) . Further work is needed to elucidate how CaN may directly or indirectly modulate RALDH activity in neurons through regulation of various phosphorylation sites.
Phosphorylation of the C-terminal sequences of AMPARs is thought to play a major role in controlling AMPAR synaptic targeting and channel properties (9) . In particular, changes in phosphorylation of the two serine residues in the C-terminal sequence of GluA1 (S831 and S845) appear to govern the conductance and trafficking of AMPARs in and out of synaptic membranes during LTP and LTD (10) (11) (12) . PKA-mediated phosphorylation of GluA1 S845 has been shown to promote plasma membrane insertion of GluA1 and synaptic retention, thereby facilitating LTP (12, (39) (40) (41) (42) (43) , whereas dephosphorylation of S845 by CaN and other phosphatases has been correlated with AMPAR endocytosis and LTD (11, 12, 40, 42) . In addition, it has been suggested that regulation of GluA1 S845 phosphorylation by PKA and CaN is involved in AMPAR trafficking during bidirectional homeostatic synaptic plasticity in cortical neurons (44, 45 ; but see ref. 46 ). However, increased phosphorylation of GluA1 S845 alone is not considered sufficient for homeostatic synaptic plasticity in the cortex (47), and does not increase AMPA synaptic targeting in the hippocampus (46) . Moreover, it was recently shown that AMPAR trafficking during LTP and RAdependent homeostatic synaptic plasticity uses different exocytosis pathways involving distinct SNARE-dependent mechanisms (48) . Thus, it is likely that the regulatory mechanisms for AMPAR trafficking are also distinct between LTP and RA-dependent homeostatic synaptic plasticity. Two recent lines of evidence further challenge the notion that the AMPAR GluA1 phosphorylation state dictates AMPAR trafficking during hippocampal synaptic plasticity. First, a study using a single-cell molecular replacement strategy found that LTP requires a reserved pool of glutamate receptors that is not subunit-specific, and that LTP expression does not require the C-terminal sequence of GluA1 (49) . Second, another study using a highly quantitative Phos-tag SDS/PAGE method estimated the proportion of the phosphorylated AMPAR subunit GluA1 in the hippocampus as <1% for S831 and <0.1% for S845 (13) . Further analysis of the postsynaptic density fraction and surface-localized AMPAR population showed that the phosphorylation of GluA1 is not significantly different from those estimated from the total population (13) . Thus, our findings, together with the foregoing lines of evidence, suggest that at least in the hippocampus, other mechanisms besides GluA1 phosphorylation are involved in regulating AMPAR trafficking during various forms of synaptic plasticity.
Results from the present study provide compelling evidence that CaN is involved in homeostatic synaptic plasticity through a mechanism independent of AMPAR phosphorylation, namely regulation of RA synthesis. First, we have demonstrated directly that blocking CaN activity induces RA synthesis. Second, we have shown that inhibition of CaN activity regulates not only excitatory synaptic strength, but also inhibitory synaptic strength, and that the latter clearly does not require GluA1 phosphorylation. Third, we have demonstrated the necessity of RA signaling in mediating the CaN blocker-induced synaptic plasticity; both inhibition of RA synthesis and genetic deletion of RARα completely block CaN inhibitor-induced synaptic plasticity. Last but not least, we have shown that in GluA1 S845A and S831A KI mutant mice, RA-, CNQX-, and CaN inhibitor-induced synaptic plasticity is intact, indicating that CaN inactivation modulates synaptic strength through a mechanism (i.e., RA signaling) distinct from direct phosphorylation of synaptic receptors. Taken together, our results provide a previously unidentified mechanism for activity-dependent regulation of RA synthesis in the context of homeostatic synaptic plasticity.
Materials and Methods
All mouse breeding colonies were maintained in the animal facility at Stanford Medical School following standard procedures approved by Stanford University's Administrative Panel on Laboratory Animal Care. Organotypic slice cultures were prepared from mouse pups at postnatal day (P) 6-7 and maintained for 5-7 d before recording (4, 50) . More details are provided in SI Materials and Methods.
